Trial intelligence / Profile preview

Multicenter phase II open-label study of cetuximab plus capecitabine as first-line treatment in elderly patients with metastatic colorectal cancer

2006-000834-11Phase 2Completed

Sponsor

Spanish Cooperative Group for Digestive Tumour Therapy

Start

Mar 2010

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1